<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Amendments</title>
	<atom:link href="http://www.tapanray.in/tag/amendments/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Growing menace of counterfeit drugs in India: why is the domestic pharmaceutical industry still so apprehensive with the new Amendments of the ACT?</title>
		<link>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2</link>
		<comments>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 00:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Amendments]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=903</guid>
		<description><![CDATA[The growing menace of Counterfeit drugs has remained a serious threat to the healthcare space of India. Do we have any credible data to assess the magnitude of this menace in India? No we do not have, as yet. At &#8230; <a href="http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
